Vitamin K deficiency: The linking pin between COPD and cardiovascular diseases?

Respiratory Research

Volumn 18, Issue 1, 2017, Pages

  Piscaer, Ianthe ^a   Wouters, Emiel F M ^a,b   Vermeer, Cees ^c   Janssens, Wim ^d   Franssen, Frits M E ^a,b   Janssen, Rob ^e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Center of Expertise for Chronic Organ Failure   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Cardiovascular diseases; COPD; Desmosine; Elastin; Matrix Gla protein; Vascular calcification; Vitamin K; Vitamin K antagonists

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; ELASTIN; FARNOQUINONE; PHYTOMENADIONE; VITAMIN K GROUP;

BLEEDING TENDENCY; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG CONTRAINDICATION; DRUG MECHANISM; HUMAN; NONHUMAN; NOTE; NUTRITIONAL STATUS; OSTEOPOROSIS; PATHOGENESIS; PATIENT CARE; PROTEIN DEGRADATION; VITAMIN INTAKE; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DIETARY SUPPLEMENT;

ANIMALS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VASCULAR CALCIFICATION; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 85033778721     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-017-0673-z     Document Type: Note

References (48)

1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557-82.
2. Williams MC, Murchison JT, Edwards LD, Agustí A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 2014;69:718-23.
3. Dransfield MT, Huang F, Nath H, Singh SP, Bailey WC, Washko GR. CT emphysema predicts thoracic aortic calcification in smokers with and without COPD. COPD. 2010;7:404-10.
4. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City heart study. Eur Respir J. 2003;21:1012-6.
5. Terzano C, Romani S, Conti V, Paone G, Oriolo F, Vitarelli A. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci. 2014;18:2908-17.
6. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009;135:786-93.
7. Verhoef TI, Redekop WK, Daly AK, van Schie RM, de Boer A. Maitland-van der zee AH. Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. Br J Clin Pharmacol. 2014;77:626-41.
8. Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewé RB, Brandenburg VM, Bekers O, Vermeer C. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost. 2010;104:811-22.
9. Willems BA, Vermeer C, Reutelingsperger CP, Schurgers LJ. The realm of vitamin K dependent proteins: shifting from coagulation toward calcification. Mol Nutr Food Res. 2014;58:1620-35.
10. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81.
11. Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P. Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol. 2008;28:856-62.
12. Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013;19:217-26.
13. Fraser JD, Price PA. Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein. Implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase. J Biol Chem. 1988;263:11033-6.
14. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matric on circulating vitamin K concentrations. Haemostasis. 2000;30:298-307.
15. Theuwissen E, Cranenburg EC, Knapen MH, Magdeleyns EJ, Teunissen KJ, Schurgers LJ, Smit E, Vermeer C. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br J Nutr. 2012;108:1652-7.
16. Shea MK, Booth SL. Concepts and controversies in evaluating vitamin K status in population-based studies. Nutrients. 2016; 10.3390/nu8010008.
17. Hanson C, Sayles H, Rutten EP, Wouters EF, MacNee W, Calverley P, Meza JL, Rennard S. The association between dietary intake and phenotypical characteristics of COPD in the ECLIPSE cohort. J COPD F. 2014;1:115-24.
18. Teichert M, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, De Smet PA, Witteman JC, Stricker BH. Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam study. Arterioscler Thromb Vasc Biol. 2008;28:771-6.
19. Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004;110:3480-7.
20. Price PA, Buckley JR, Williamson MK. The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr. 2001;131:2910-5.
21. Mithieux SM, Weiss AS. Elastin. Adv Protein Chem. 2005;70:437-61.
22. Rucker RB. Calcium binding to elastin. Adv Exp Med Biol. 1974;48:185-209.
23. Weijs B, Blaauw Y, Rennenberg RJ, Schurgers LJ, Timmermans CC, Pison L, Nieuwlaat R, Hofstra L, Kroon AA, Wildberger J, et al. Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J. 2011;32:2555-62.
24. Rennenberg RJ, van Varik BJ, Schurgers LJ, Hamulyak K, Ten Cate H, Leiner T, Vermeer C, de Leeuw PW, Kroon AA. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 2010;115:5121-3.
25. Maclay JD, McAllister DA, Rabinovich R, Haq I, Maxwell S, Hartland S, Connell M, Murchison JT, van Beek EJ, Gray RD, et al. Systemic elastin degradation in chronic obstructive pulmonary disease. Thorax. 2012;67:606-12.
26. Casaburi R, Celli B, Crapo J, Criner G, Croxton T, Gaw A, Jones P, Kline-Leidy N, Lomas DA, Merrill D, et al. The COPD biomarker qualification consortium (CBQC). COPD. 2013;10:367-77.
27. Turino GM, Ma S, Cantor JO, Lin YY. The effect of Alpha-1 Proteinase inhibitor on biomarkers of Elastin degradation in Alpha-1 antitrypsin deficiency: an analysis of the RAPID/RAPID extension trials. Chronic Obstr Pulm Dis (Miami). 2017;4:34-44.
28. Rabinovich RA, Miller BE, Wrobel K, Ranjit K, Williams MC, Drost E, Edwards LD, Lomas DA, Rennard SI, Agustí A, et al. Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD. Eur Respir J. 2016;47:1365-73.
29. Lee JS, Basalyga DM, Simionescu A, Isenburg JC, Simionescu DT, Vyavahare NR. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006;168:490-8.
30. Romme EA, McAllister DA, Murchison JT, Van Beek EJ, Petrides GS, Price CO, Rutten EP, Smeenk FW, Wouters EF, MacNee W. Associations between COPD related manifestations: a cross-sectional study. Respir Res. 2013; 10.1186/1465-9921-14-129.
31. Romme EA, Murchison JT, Edwards LD, van Beek E Jr, Murchison DM, Rutten EP, Smeenk FW, Williams MC, Wouters EF, MacNee W, et al. CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes. J Bone Miner Res. 2013;28:1369-77.
32. Knapen MH, Braam LA, Drummen NE, Bekers O, Hoeks AP, Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost. 2015;113:1135-44.
33. Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24:2499-507.
34. de Brouwer B, Spanbroek M, Drummen N, van den Ouweland J, Zanen P, Vermeer C, Janssen R. Low vitamin K status is associated with COPD and accelerated degradation of mature elastin [abstract]. Am J Respir Crit Care Med. 2016;193:A4134.
35. Molitor H, Robinson HJ. Oral and parenteral toxicity of vitamin K1, phthicol and 2-methyl-1,4-naphthoquinone. Proc Soc Exp Biol Med. 1940;43:125-8.
36. Stern D, Brett J, Harris K, Nawroth P. Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S. J Cell Biol. 1986;102:1971-8.
37. McCann JC, Ames BN. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr. 2009;90:889-907.
38. Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, Kwaijtaal M, Brandenburg VM, Ketteler M, Schurgers LJ. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res. 2008;45:427-36.
39. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. J Nutr. 2004;134:3100-5.
40. Gast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, van der Schouw YT. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009;19:504-10.
41. Brandenburg VM, Reinartz S, Kaesler N, Krüger T, Dirrichs T, Kramann R, Peeters F, Floege J, Keszei A, Marx N, et al. Slower progress of aortic valve calcification with vitamin K supplementation: results from a prospective interventional proof-of-concept study. Circulation. 2017;135:2081-3.
42. London GM, Cohn JN. Prognostic application of arterial stiffness: task forces. Am J Hypertens. 2002;15:754-8.
43. Vivodtzev I, Tamisier R, Baguet JP, Borel JC, Levy P, Pépin JL. Arterial stiffness in COPD. Chest. 2014;145:861-75.
44. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood. 2007;109:2823-31.
45. Price PA, Toroian D, Lim JE. Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem. 2009;284:17092-101.
46. Piscaer I, Drummen NE, van den Ouweland JM, Spanbroek M, Bloem-de Vries L, Franssen FM, Wouters EF, Vermeer C, Janssen R. The effect of vitamin K antagonists on rates of Elastin degradation: potential implications for chronic pulmonary diseases [abstract]. Am J Respir Crit Care Med. 2017;195:A1053.
47. Caluwé R, Pyfferoen L, De Boeck K, De Vriese AS. The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials. Clin Kidney J. 2016;9:273-9.
48. Heulens N, Korf H, Cielen N, De Smidt E, Maes K, Gysemans C, Verbeken E, Gayan-Ramirez G, Mathieu C, Janssens W. Vitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed mice. Respir Res. 2015;16:110. 10.1186/s12931-015-0271-x.